Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 (LYEL)

Historical Holders from Q2 2025 to Q3 2025

Symbol
LYEL on Nasdaq
CUSIP
55083R203
Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
19.1M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
9.64M
Holdings value
$154M
% of all portfolios
0.005%
Grand Portfolio weight change
+0%
Number of holders
56
Number of buys
24
Number of sells
-30
Average Value change %
+0%
Average buys %
+0.003%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 (LYEL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARCH Venture Fund IX, L.P. 13% $44.8M 2.76M ARCH Venture Fund IX, L.P. Sep 30, 2025
Innovative Cellular Therapeutics Holdings Ltd 9.8% $30.9M 1.9M Innovative Cellular Therapeutics Holdings Ltd Nov 6, 2025
Foresite Capital Fund IV, L.P. 7.6% $23.6M 1.45M James B. Tananbaum Sep 30, 2025
Gates Frontier, LLC 5.6% 1.04M Gates Frontier, LLC Jul 25, 2025
NEWTON (PTC) Ltd 3.93% $12.3M 755K Newton (PTC) Limited Sep 30, 2025

Institutional Holders of Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 (LYEL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 9.64M $154M +$47.8M $16.24 56
2025 Q2 6.82M $60.3M +$60.3M $8.84 62